Procurement Summary
Country: Poland
Summary: Delivery of the Medicinal Product Mirvetuximab Soravtansine as Part of the B.50 Drug Program Treatment of Patients with Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer - 1 Product Package
Deadline: 11 Dec 2025
Posting Date: 30 Oct 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 129174189
Document Ref. No.: 719956-2025
Competition: ICB
Financier: Other Funding Agencies
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33600000 - Pharmaceutical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Delivery of the medicinal product Mirvetuximab soravtansine under the B.50 Drug Program
TREATMENT OF PATIENTS WITH OVARIAN CANCER, Fallopian tube cancer or peritoneal cancer - 1 assortment package
Mirvetuximab soravtansine 5 mg/ml concentrate for preparation
solution for infusion, 20 ml vial
Doc Title: Product Delivery medicinal product Mirvetuximab soravtansine as part of the B.50 Drug Program TREATMENT OF PATIENTS WITH OVARIAN CANCER, Fallopian tube cancer or peritoneal cancer - 1 assortment package
Contract Type: supplies
Document Type: Contract Notice
Reference Number: DZP/254/2025
Contract Type: supplies
Authority Type: eu-ins-bod-ag
Doc Title: Delivery of the medicinal product Mirvetuximab soravtansine as part of the B.50 Drug Program TREATMENT OF PATIENTS WITH OVARIAN CANCER, Fallopian tube cancer or peritoneal cancer - 1 package asortymentowy
Dispatch Date: 2025-10-29
Publish Date: 2025-10-30
Submission Date: 2025-12-11
Documents
Tender Notice